Interaction between RAAS inhibitors and ACE2 in the context of COVID-19

Interaction between RAAS inhibitors and ACE2 in the context of COVID-19

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews cardiology 2020-05, Vol.17 (5), p.313-313
Hauptverfasser: Mourad, Jean-Jacques, Levy, Bernard I.
Format: Artikel
Sprache:eng
Schlagworte:
692/4019/592/75/243
692/420/254
692/699/255
Angiotensin-Converting Enzyme 2
Betacoronavirus
Cardiac Imaging
Cardiac Surgery
Cardiology
Cardiovascular System
Coronavirus Infections
Correspondence
COVID-19
Humans
Medicine
Medicine & Public Health
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
Renin-Angiotensin System - drug effects
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 313
container_issue 5
container_start_page 313
container_title Nature reviews cardiology
container_volume 17
creator Mourad, Jean-Jacques
Levy, Bernard I.
description
doi_str_mv 10.1038/s41569-020-0368-x
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7104419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A621196898</galeid><sourcerecordid>A621196898</sourcerecordid><originalsourceid>FETCH-LOGICAL-c596t-810949736fc5ada1add98f39091a5517d9b94a1297d7f6bf0f0d7aa0ab4f4cbc3</originalsourceid><addsrcrecordid>eNp9kl1rFDEUhgdRbK3-AG9kQJDeTD1JJpPJjTCstS4UCn7dhkwm2UmZTWqS0e2_N8vWbVdUcpFwzvOenK-ieIngDAFp38Ya0YZXgKEC0rTV5lFxjBjlFQUEj_dvwEfFsxivAZqaUfK0OCIYE0Rwe1xcLF3SQapkvSt7nX5q7cpPXfe5tG60vU0-xFK6oewW5zjbyjTqUvks2qTSm3Jx9W35vkL8efHEyCnqF3f3SfH1w_mXxcfq8upiueguK0V5k6oWAa85I41RVA4SyWHgrSEcOJKUIjbwntcSYc4GZpregIGBSQmyr02tekVOine7uDdzv9aD0i4FOYmbYNcy3AovrTj0ODuKlf8hGIK6RjwHOL0LEPz3Wcck1jYqPU3SaT9HgUlLMeMYWEZf_4Fe-zm4XJ7AuZFAKa__TxGOMDR5PvfUSk5aWGd8zk5tvxZdgxHiTcvbTJ39hcpn0Gubu66NzfYDwZsHglHLKY3RT_N2nPEQRDtQBR9j0GbfMgRiu0xit0wiJyu2yyQ2WfPqYa_3it_bkwG8A2J2uZUO96X_O-ov5-jQUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2391206020</pqid></control><display><type>article</type><title>Interaction between RAAS inhibitors and ACE2 in the context of COVID-19</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Mourad, Jean-Jacques ; Levy, Bernard I.</creator><creatorcontrib>Mourad, Jean-Jacques ; Levy, Bernard I.</creatorcontrib><identifier>ISSN: 1759-5002</identifier><identifier>EISSN: 1759-5010</identifier><identifier>DOI: 10.1038/s41569-020-0368-x</identifier><identifier>PMID: 32231328</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/4019/592/75/243 ; 692/420/254 ; 692/699/255 ; Angiotensin-Converting Enzyme 2 ; Betacoronavirus ; Cardiac Imaging ; Cardiac Surgery ; Cardiology ; Cardiovascular System ; Coronavirus Infections ; Correspondence ; COVID-19 ; Humans ; Medicine ; Medicine &amp; Public Health ; Pandemics ; Peptidyl-Dipeptidase A ; Pneumonia, Viral ; Renin-Angiotensin System - drug effects ; SARS-CoV-2</subject><ispartof>Nature reviews cardiology, 2020-05, Vol.17 (5), p.313-313</ispartof><rights>Springer Nature Limited 2020</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>Springer Nature Limited 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c596t-810949736fc5ada1add98f39091a5517d9b94a1297d7f6bf0f0d7aa0ab4f4cbc3</citedby><cites>FETCH-LOGICAL-c596t-810949736fc5ada1add98f39091a5517d9b94a1297d7f6bf0f0d7aa0ab4f4cbc3</cites><orcidid>0000-0003-0877-8311</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41569-020-0368-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41569-020-0368-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32231328$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mourad, Jean-Jacques</creatorcontrib><creatorcontrib>Levy, Bernard I.</creatorcontrib><title>Interaction between RAAS inhibitors and ACE2 in the context of COVID-19</title><title>Nature reviews cardiology</title><addtitle>Nat Rev Cardiol</addtitle><addtitle>Nat Rev Cardiol</addtitle><subject>692/4019/592/75/243</subject><subject>692/420/254</subject><subject>692/699/255</subject><subject>Angiotensin-Converting Enzyme 2</subject><subject>Betacoronavirus</subject><subject>Cardiac Imaging</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Cardiovascular System</subject><subject>Coronavirus Infections</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Pandemics</subject><subject>Peptidyl-Dipeptidase A</subject><subject>Pneumonia, Viral</subject><subject>Renin-Angiotensin System - drug effects</subject><subject>SARS-CoV-2</subject><issn>1759-5002</issn><issn>1759-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kl1rFDEUhgdRbK3-AG9kQJDeTD1JJpPJjTCstS4UCn7dhkwm2UmZTWqS0e2_N8vWbVdUcpFwzvOenK-ieIngDAFp38Ya0YZXgKEC0rTV5lFxjBjlFQUEj_dvwEfFsxivAZqaUfK0OCIYE0Rwe1xcLF3SQapkvSt7nX5q7cpPXfe5tG60vU0-xFK6oewW5zjbyjTqUvks2qTSm3Jx9W35vkL8efHEyCnqF3f3SfH1w_mXxcfq8upiueguK0V5k6oWAa85I41RVA4SyWHgrSEcOJKUIjbwntcSYc4GZpregIGBSQmyr02tekVOine7uDdzv9aD0i4FOYmbYNcy3AovrTj0ODuKlf8hGIK6RjwHOL0LEPz3Wcck1jYqPU3SaT9HgUlLMeMYWEZf_4Fe-zm4XJ7AuZFAKa__TxGOMDR5PvfUSk5aWGd8zk5tvxZdgxHiTcvbTJ39hcpn0Gubu66NzfYDwZsHglHLKY3RT_N2nPEQRDtQBR9j0GbfMgRiu0xit0wiJyu2yyQ2WfPqYa_3it_bkwG8A2J2uZUO96X_O-ov5-jQUg</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Mourad, Jean-Jacques</creator><creator>Levy, Bernard I.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0877-8311</orcidid></search><sort><creationdate>20200501</creationdate><title>Interaction between RAAS inhibitors and ACE2 in the context of COVID-19</title><author>Mourad, Jean-Jacques ; Levy, Bernard I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c596t-810949736fc5ada1add98f39091a5517d9b94a1297d7f6bf0f0d7aa0ab4f4cbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>692/4019/592/75/243</topic><topic>692/420/254</topic><topic>692/699/255</topic><topic>Angiotensin-Converting Enzyme 2</topic><topic>Betacoronavirus</topic><topic>Cardiac Imaging</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Cardiovascular System</topic><topic>Coronavirus Infections</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Pandemics</topic><topic>Peptidyl-Dipeptidase A</topic><topic>Pneumonia, Viral</topic><topic>Renin-Angiotensin System - drug effects</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mourad, Jean-Jacques</creatorcontrib><creatorcontrib>Levy, Bernard I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nature reviews cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mourad, Jean-Jacques</au><au>Levy, Bernard I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction between RAAS inhibitors and ACE2 in the context of COVID-19</atitle><jtitle>Nature reviews cardiology</jtitle><stitle>Nat Rev Cardiol</stitle><addtitle>Nat Rev Cardiol</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>17</volume><issue>5</issue><spage>313</spage><epage>313</epage><pages>313-313</pages><issn>1759-5002</issn><eissn>1759-5010</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32231328</pmid><doi>10.1038/s41569-020-0368-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0877-8311</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1759-5002
ispartof Nature reviews cardiology, 2020-05, Vol.17 (5), p.313-313
issn 1759-5002
1759-5010
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7104419
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects 692/4019/592/75/243
692/420/254
692/699/255
Angiotensin-Converting Enzyme 2
Betacoronavirus
Cardiac Imaging
Cardiac Surgery
Cardiology
Cardiovascular System
Coronavirus Infections
Correspondence
COVID-19
Humans
Medicine
Medicine & Public Health
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
Renin-Angiotensin System - drug effects
SARS-CoV-2
title Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A24%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20between%20RAAS%20inhibitors%20and%20ACE2%20in%20the%20context%20of%20COVID-19&rft.jtitle=Nature%20reviews%20cardiology&rft.au=Mourad,%20Jean-Jacques&rft.date=2020-05-01&rft.volume=17&rft.issue=5&rft.spage=313&rft.epage=313&rft.pages=313-313&rft.issn=1759-5002&rft.eissn=1759-5010&rft_id=info:doi/10.1038/s41569-020-0368-x&rft_dat=%3Cgale_pubme%3EA621196898%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2391206020&rft_id=info:pmid/32231328&rft_galeid=A621196898&rfr_iscdi=true